Long-Term Debt: The sum of all long term debt fields.
Definium Therapeutics, Inc. (DFTX) had Long-Term Debt of $36.47M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-158.99M |
|
-- |
|
-- |
|
$75.08M |
|
$-75.08M |
|
$-83.91M |
|
$-158.99M |
|
$-158.99M |
|
$-158.99M |
|
$-158.99M |
|
$-158.99M |
|
$-158.99M |
|
$-75.08M |
|
$-76.44M |
|
110.69M |
|
110.69M |
|
$-1.44 |
|
$-1.44 |
|
| Balance Sheet Financials | |
$1.09B |
|
-- |
|
$20.80M |
|
$1.11B |
|
$157.20M |
|
|
Long-Term Debt |
$36.47M |
$37.02M |
|
$194.22M |
|
$918.68M |
|
$898.76M |
|
$918.68M |
|
134.37M |
|
| Cash Flow Statement Financials | |
$-95.41M |
|
$-274.74M |
|
$767.58M |
|
$257.84M |
|
$655.27M |
|
$397.43M |
|
$16.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.95 |
|
-- |
|
-- |
|
0.04 |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-95.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.31% |
|
-17.69% |
|
-14.29% |
|
-16.65% |
|
$6.84 |
|
$-0.86 |
|
$-0.86 |
|